Asia Pacific Markets for Spinal Implants, MIS and VCF 2009 (4 Countries)

Content

• 1 Executive Summary
  • 1.1 Asia -pacific Market for Spinal Implants
  • 1.2 Asia -pacific Fusion Market
  • 1.3 Traditional Thoracolumbar Fixation Devices
  • 1.4 Traditional Cervical Fixation Devices
  • 1.5 Interbody Fusion Devices
  • 1.6 Vcf Market
  • 1.7 Non -fusion Market
  • 1.8 Artificial Discs
  • 1.9 Dynamic Stabilization
  • 1.10 Leading Competitors
• 2 Research Methodology
  • 2.1 Research Scope
  • 2.2 Idata's 9-step Methodology
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research.
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research.
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis .
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release .
    • Step 9: Customer Feedback and Market Monitoring 12
  • 3.1 Introduction
  • 3.2 Product Summary
    • 3.2.1 Overview
    • 3.2.2 Thoracolumbar Fixation Devices
      • 3.2.2.1 Degenerative Cases .15
      • 3.2.2.2 Deformity .16
      • 3.2.2.3 Trauma/Tumor.16
    • 3.2.3 Cervical Fixation Devices 16
      • 3.2.3.1 Cervical Anterior Plates 16
      • 3.2.3.2 Cervical Posterior Devices17
    • 3.2.4 Interbody Fusion Implants 17
      • 3.2.4.1 ALIF.18
      • 3.2.4.2 PLIF.18
      • 3.2.4.3 TLIF .18
      • 3.2.4.4 Cervical .18
      • 3.2.4.5 Non-bone .19
      • 3.2.4.6 Machined Bone 19
    • 3.2.5 Artificial Discs 20
    • 3.2.6 Dynamic Stabilization
    • 3.2.7 VCF Treatments 21
      • 3.2.7.1 Percutaneous Vertebroplasty.21
      • 3.2.7.2 Kyphoplasty .22
  • 3.3 Currency Exchange Rates
  • 3.4 Market Analysis & Forecast by Segment
    • 3.4.1 Market Overview
    • 3.4.2 Fusion Market
    • 3.4.3 Artificial Discs 30
    • 3.4.4 Dynamic Stabilization
    • 3.4.5 VCF Treatments 34
    • 3.4.6 MIS Fusion Market
  • 3.5 Trend Analysis by Country
  • 3.6 Market Drivers & Limiters
    • 3.6.1 Market Drivers 40
      • 3.6.1.1 Aging Population.40
      • 3.6.1.2 Patient Demand for Non-Fusion Technology40
      • 3.6.1.3 Reimbursement 40
    • 3.6.2 Market Limiters
      • 3.6.2.1 Cost Containment/Pricing Pressure 41
      • 3.6.2.2 Lack of Funding/Reimbursement.41
      • 3.6.2.3 Domestic Competitors .41
  • 3.7 Leading Competitors
    • 3.7.1 Competitive Analysis
  • 3.8 Mergers and Acquisitions
    • 3.8.1 Zimmer ??